thymidine 5'-triphosphate has been researched along with Sarcoma 180 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bover, L; Cabral, S; Leis, S; Mordoh, J; Nembrot, M | 1 |
| Anai, H; Emi, Y; Kusumoto, T; Maehara, Y; Sakaguchi, Y; Sugimachi, K | 1 |
2 other study(ies) available for thymidine 5'-triphosphate and Sarcoma 180
| Article | Year |
|---|---|
Dipyridamole inhibits reversion by thymidine of methotrexate effect and increases drug uptake in Sarcoma 180 cells.
Topics: Animals; Biological Transport; Deoxycytidine; Deoxyuridine; Dipyridamole; DNA Replication; Drug Antagonism; Kinetics; Methotrexate; Mice; Sarcoma 180; Thymidine; Thymine Nucleotides | 1984 |
Detection of DNA strand breaks in HeLa cells in vitro and in mouse sarcoma 180 cells in vivo induced by an alkylating agent, carboquone, using in situ nick translation.
Topics: Animals; Autoradiography; Azirines; Carbazilquinone; DNA Damage; Dose-Response Relationship, Drug; HeLa Cells; Humans; Male; Mice; Sarcoma 180; Thymine Nucleotides | 1990 |